Angela Maggard, MD
Obstetrics & Gynecology · Pikeville, KYNPI 1811981442
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (55.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 64.7% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2021 at $8,160 and has fallen 91.8% since, to $668 in 2025. Among obstetrics & gynecology clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 199 payments — averaging $55.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- AbbVie$1K
- Daiichi Sankyo Inc.$479
- Mayne Pharma Commercial LLC$376
- Sumitomo Pharma America, Inc.$314
- Channel Medsystems, Inc.$155
- plus $1K from 30 others
What the payments were for
- Travel & lodging$1,06710%
- Food & beverage$3,87535%
- Education$6,09555%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 10 | $7,140 |
| AbbVie | 59 | $1,149 |
| Daiichi Sankyo Inc. | 29 | $479 |
| Mayne Pharma Commercial LLC | 2 | $376 |
| Sumitomo Pharma America, Inc. | 21 | $314 |
| Channel Medsystems, Inc. | 1 | $155 |
| Astellas Pharma US Inc | 5 | $148 |
| Exeltis, USA Inc. | 9 | $142 |
| Covidien LP | 3 | $133 |
| Sage Therapeutics, LLC | 6 | $105 |
| Pfizer | 7 | $105 |
| Shield Therapeutics Inc | 2 | $76 |
| Amgen | 5 | $73 |
| Merck | 4 | $58 |
| Myovant Sciences Inc. | 3 | $54 |
| Bausch Health US, LLC | 3 | $47 |
| Pacira Pharmaceuticals Incorporated | 2 | $36 |
| Hologic Sales And Service, LLC | 2 | $34 |
| GSK | 2 | $34 |
| Abbott | 2 | $33 |
| Bayer | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Organon | 2 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Lilly USA, LLC | 2 | $28 |
| Dexcom, Inc. | 1 | $25 |
| Sobi, Inc | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Novartis | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Meditrina | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$7,048
How this compares
$11,036 in reported general payments places this provider in the 95th percentile of 474 obstetrics & gynecology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 33 | $41,516 |
| MyrbetriqMirabegron | 85 | $37,191 |
| Lupron DepotLeuprolide Acetate | 17 | $29,145 |
| MounjaroTirzepatide | 18 | $18,359 |
| Estradiol | 581 | $15,596 |
| LinzessLinaclotide | 24 | $15,470 |
| PremarinEstrogens, Conjugated | 22 | $10,007 |
| Imipramine Pamoate | 17 | $3,035 |
| Clobetasol Propionate | 78 | $2,564 |
| Estradiol (Once Weekly)Estradiol | 35 | $2,436 |
| Norethindron-Ethinyl EstradiolNorethindrone Ac/Eth Estradiol | 38 | $1,890 |
| FyavolvNorethindrone Ac/Eth Estradiol | 49 | $1,862 |
| Spironolactone | 68 | $1,669 |
| ProgesteroneProgesterone, Micronized | 87 | $1,663 |
| Oxybutynin Chloride ErOxybutynin Chloride | 85 | $1,351 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLupron Depot, Linzess | $1,149 | $44,61541 claims |
| Novo NordiskOzempic | $15 | $41,51633 claims |
| Astellas Pharma US IncMyrbetriq | $148 | $37,19185 claims |
| Lilly USA, LLCMounjaro | $28 | $18,35918 claims |
| PfizerPremarin | $105 | $10,00722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 474 obstetrics & gynecology providers in Kentucky.
Other obstetrics & gynecology in Pikeville
- Nathan SticeBowling Green$199K
- John BrunerSomerset$82K
- Resad PasicLouisville$39K
- Wendy JacksonLexington$37K
- Bradley YoukilisLouisville$29K
- Travis GilbertCorbin$28K
- James GuilerLexington$25K
- Gigi GirardLouisville$23K
- Jonathan AbbottHopkinsville$18K
- Matthew PriceMurray$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.